Pegunigalsidase alfa

pegunigalsidase alfa · Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Pegunigalsidase alfa, covering 2024-07-31 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease [Phase 3]